Clinical Trials Browser

OTHER × Interventional × Rosiglitazone × Clear all

Adenocarcinoma Of Esophagus, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hepatocellular, Melanoma

NCT00004180 2023-06-26

Rosiglitazone in Treating Patients With Liposarcoma

Phase 2 Completed

32 enrolled

Sarcoma

Liposarcoma, Sarcoma

NCT01019356 2022-01-20

Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome

Phase NA Completed

52 enrolled

Polycystic Ovary Syndrome

NCT00616642 2020-08-14

Rosiglitazone in Treating Patients With Pituitary Tumors

Phase 2 Terminated

1 enrolled 4 charts

CNSEndocrine

Pituitary Neoplasms, Central Nervous System Neoplasms

NCT00640224 2017-11-17

Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study

Phase 4 Completed

65 enrolled 28 charts

Polycystic Ovary Syndrome

NCT03309319 2017-10-13

A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas

Phase NA Unknown

24 enrolled

Endocrine

Pituitary Neoplasms

NCT00933309 2016-02-19

The Impact of Obesity and Obesity Treatments on Breast Cancer

Phase 1 Completed

25 enrolled

BreastOther

Breast Neoplasms, Obesity

NCT00178841 2016-02-17

Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL

Phase 2 Completed

4 enrolled 5 charts

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT00084578 2013-07-15

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Phase NA Withdrawn

Genitourinary

Urinary Bladder Neoplasms

NCT00182052 2013-05-23

Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer

Phase 3 Completed

100 enrolled